Together, We Can Overcome Addiction In pursuit of our mission to be a force of healing and hope for individuals, families and communities affected by addiction, the Hazelden Betty Ford Foundation has mobilized our entire organization to comprehensively confront the national opioid epidemic—and to make our addiction treatment practices and knowledge available in ways that can be used in communities and health care organizations anywhere. In addition to public education and policy efforts, our clinical teams have developed the field’s most innovative approach to treating opioid addiction. Hazelden Publishing is leading the way in bringing our knowledge, experience and solutions to communities, professionals and health care providers. Joining Together the Best Evidenced-based Practices to Establish a New Clinical Care Model: The Comprehensive Opioid Response with Twelve Steps (COR-12®) In 2012, Hazelden launched a new addiction treatment protocol designed to address the grim reality that more people were becoming addicted to heroin and other opioids, and dying from overdose. Of particular concern was the risk that patients whose tolerance decreased during abstinence could relapse and easily overdose just by taking the same doses they used to take. Our new protocol—Comprehensive Opioid Response with Twelve Steps, or COR-12—embraces the latest research indicating how certain medications can be used to improve recovery outcomes for people with opiate addiction. The medication-assisted treatment aspects of COR-12 are fully integrated into the Hazelden Betty Ford Foundation’s care model, which utilizes other evidence-based practices like Twelve Step facilitation, cognitive-behavioral therapy and motivational interviewing. The Hazelden Betty Ford Foundation’s COR-12 team includes medical, clinical and research professionals whose collective goal is to improve the lives of those suffering from heroin and other opioid addiction. Our program encompasses the full spectrum of addiction, including ongoing recovery management and lifelong recovery support services. The COR-12 addiction treatment path includes group therapy and lectures that focus on opioid addiction as well as providing two extended medication assistance options under closely supervised care: 1) use of buprenorphine/naloxone (Suboxone®); or 2) use of extended-release naltrexone (Vivitrol®). Patients also can choose to participate in COR-12 without medication assistance. Learn more about the COR-12 opioid addiction treatment program. "We use medications to engage our opioid-dependent patients long enough to allow them to complete treatment and become established in solid Twelve Step recovery," said the Foundation's chief medical officer Dr. Marvin Seppala. "Our goal will always be to pursue a personalized treatment plan for our patients, which may include the use of medication and embrace multiple pathways to recovery." Hazelden Betty Ford Foundation Responds to the Opioid Crisis America is in the midst of an opioid crisis that now claims more lives than car accidents. Hear president and CEO Mark Mishek discuss the Foundation’s response with COR-12 program. Joining Forces with Communities to Confront the Opioid Epidemic The impact of the opioid epidemic is felt in families, law enforcement, health care, schools and virtually every segment of society. Hazelden Publishing’s Solution and Training Team has joined forces with communities throughout the United States to hold community mobilization events focused on confronting the opioid crisis. By partnering with community leaders in health care, treatment, education and law enforcement—along with community coalition groups—we’re helping thousands of people become more aware of both the problem and its solutions. Our one-day community-wide mobilization training events help community leaders: Understand the history and current impact of heroin and prescription painkiller use in their community Identify resources for prevention, intervention and referrals to treatment Develop a community-based action plan for addressing the opioid epidemic Joining Forces with Organizations to Ensure Effective, Evidence-based Treatment Is Available to Everyone Hazelden Publishing’s Solution and Training Team also supports other health care and treatment organizations in the execution of a five-point plan designed to comprehensively address the opioid epidemic in their communities. This approach combines the prevention of opioid misuse in communities with effective treatment and support for lifelong recovery through a five-step model. Mobilize communities with heroin and prescription painkiller community mobilization events. Plan by hosting or attending a three-day clinical leadership training event. Assess the current state of readiness with an onsite readiness assessment. Train clinical staff on implementation of the COR-12® model within current treatment delivery systems. Support leadership and front-line staff through professional learning communities. The same COR-12 model of care that has been implemented at the Hazelden Betty Ford Foundation’s addiction treatment clinics is now helping others in states such as Kentucky, which have been hit hard by the opioid epidemic. As similar partnerships are developed with organizations throughout the nation, access to effective opioid addiction treatment for all transforms from hope to reality. Joining Forces with Professionals to Deliver Evidence-based Solutions As the world leader in developing evidence-based treatment materials, Hazelden Publishing has been focused on delivering materials that help communities prevent opioid addiction and overdose deaths, along with resources organizations can use to effectively treat opiate addiction, with a focus on lifelong recovery. Our Hazelden Publishing team travels the nation, listening to the challenges and successes of others and responding with tools that make a difference. Joining Forces with Primary Health Care Professionals The Hazelden Betty Ford Foundation offers Professionals in Residence (PIR) programs in Minnesota and California, providing doctors and other health care professionals the opportunity to learn how to recognize and assess substance use disorders, including opioid addiction. These programs bring professionals to our facilities where they are immersed in the patient’s treatment experience for a week while also learning through lectures and clinical observation. The experiential model provides an in-depth, personal and unique learning experience that tends to stick with participants. PIR staff also host special events such as recent conferences on Addiction Medicine for the Primary Care Provider, where much of the discussion revolves around opioids. Such events demonstrate how our PIR programs can help us address the nation’s opioid crisis. Learn more about the Professional in Residence programs. Another leverage point in the fight against opioid overprescribing is our Summer Institute for Medical Students (SIMS). The SIMS program, like our PIR programs, gives students the opportunity to be part of the addiction treatment experience for one week. Students learn from our clinicians as well as by shadowing patients and family program participants. The idea is to help our nation’s future doctors understand the recovery process by letting them see it happen. By educating future physicians about the risks of overprescribing opioids, and how to recognize and treat opioid addiction, the SIMS program serves as a powerful model and resource. Participants frequently describe the experience as profound and enlightening. Learn more about the Summer Institute for Medical Students program. In Minnesota and Oregon, we also offer a specialty treatment track for professionals who become addicted to opioids and other drugs. The program helps professionals recover from addiction, salvage their careers and eventually re-enter the workforce as advocates for addiction prevention and recovery. Recovering professionals, whether or not they publicly disclose their recovery status, are valuable allies in efforts to promote more cautious opioid prescribing practices and other measures to address the epidemic.